ROCURONIUM BROMIDE INJECTION DIN 02517744
Health Canada record
| Active ingredient(s) | ROCURONIUM BROMIDE 10 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M03AC09 ROCURONIUM BROMIDE |
| Original market date | 29-Sep-2023 |
| Current status date | 29-Sep-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hikma Canada Limited — licence 3-002579, currently licensed, last inspection rating C (2022-04-26).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ROCURONIUM BROMIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02469774 | ROCURONIUM BROMIDE INJECTION | JUNO PHARMA CANADA INC. | Solution | ROCURONIUM BROMIDE 10 MG | Marketed |
| 02529831 | ROCURONIUM BROMIDE INJECTION | JAMP PHARMA CORPORATION | Solution | ROCURONIUM BROMIDE 10 MG | Marketed |
| 02318415 | ROCURONIUM BROMIDE INJECTION | SANDOZ CANADA INCORPORATED | Solution | ROCURONIUM BROMIDE 10 MG | Marketed |
| 02528657 | ROCURONIUM BROMIDE INJECTION | EUGIA PHARMA INC. | Solution | ROCURONIUM BROMIDE 10 MG | Marketed |
| 02498820 | ROCURONIUM BROMIDE INJECTION | AURO PHARMA INC | Solution | ROCURONIUM BROMIDE 10 MG | Marketed |
| 02442752 | ROCURONIUM BROMIDE INJECTION | STERIMAX INC | Solution | ROCURONIUM BROMIDE 10 MG | Approved |
| 02539489 | INJECTABLE ROCURONIUM BROMIDE | OMEGA LABORATORIES LIMITED | Solution | ROCURONIUM BROMIDE 10 MG | Cancelled Pre Market |
| 02382415 | ROCURONIUM BROMIDE INJECTION | OMEGA LABORATORIES LIMITED | Solution | ROCURONIUM BROMIDE 10 MG | Cancelled Post Market |
| 02318121 | ROCURONIUM BROMIDE INJECTION | PFIZER CANADA ULC | Solution | ROCURONIUM BROMIDE 10 MG | Cancelled Post Market |
| 02390566 | ROCURONIUM BROMIDE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | ROCURONIUM BROMIDE 10 MG | Cancelled Pre Market |
| 02108208 | ZEMURON | MERCK CANADA INC | Solution | ROCURONIUM BROMIDE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 26238 | 2021-07-09 | Abbreviated New Drug Submission (ANDS) |
International API supply for ROCURONIUM BROMIDE
9 valid EDQM Certificates of Suitability from 9 holders. 14 active FDA Drug Master Files.
Request a quote for ROCURONIUM BROMIDE INJECTION